RT Journal Article
SR Electronic
T1 A collaborative network trial to evaluate the effectiveness of implementation strategies to maximise adoption of a school-based healthy lunchbox program: A study protocol
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.19.23298746
DO 10.1101/2023.11.19.23298746
A1 Barnes, Courtney
A1 Jones, Jannah
A1 Wolfenden, Luke
A1 Robertson, Katie
A1 Seidler, Anna Lene
A1 Norman, Jennifer
A1 Budgen, Pip
A1 Mattingly, Megan
A1 Piliskic, Carla
A1 Moorhouse, Lisa
A1 Mozina, Jennifer
A1 Plaskett, Jennifer
A1 McDermott, Sarah
A1 Darney, Sara
A1 Vuong, Cecilia
A1 Douglass, Nina
A1 McDonnell, Kara
A1 Sutherland, Rachel
YR 2023
UL http://medrxiv.org/content/early/2023/11/20/2023.11.19.23298746.abstract
AB Background Schools provide universal access to children over five years of age, representing a key opportunity for nutrition interventions to prevent the development of chronic disease. However, an important impediment to the large-scale adoption of evidence-based school nutrition interventions is the lack of evidence on effective strategies to implement them. This paper describes the protocol for a “Collaborative Network Trial” to support the simultaneous testing of different strategies undertaken by New South Wales Local Health Districts to facilitate the adoption of an effective school-based healthy lunchbox program (‘SWAP IT’). The primary objective of this study is to assess the effectiveness of different implementation strategies to increase school adoption of the SWAP across New South Wales Local Health Districts.Methods Within a Master Protocol framework, a collaborative network trial will be undertaken. Independent randomised controlled trials to test implementation strategies to increase school adoption of SWAP IT within primary schools in 10 different New South Wales Local Health Districts will occur. Schools within each Local Health District will be randomly allocated to either the intervention or control condition. Schools allocated to the intervention group will receive a combination of implementation strategies developed by each of the Local Health Districts independently, based on their existing capacities and local contexts. Across the 10 participating Local Health Districts, six broad strategies were developed and combinations of these strategies will be executed over a 6 month period. In six districts an active comparison group (containing one or more implementation strategies) was selected. The primary outcome of the trial will be adoption of SWAP IT, assessed via electronic registration records captured automatically following online school registration to the program. The primary trial outcome, between-group differences at 6 month follow-up, will be assessed using logistic regression analyses for each trial. Individual participant data component network meta-analysis, under a Bayesian framework, will be used to explore strategy-covariate interactions; to model additive main effects (separate effects for each component of an implementation strategy); two way interactions (synergistic/antagonistic effects of components), and full interactions.Discussion The study will provide rigorous evidence of the effects of a variety of implementation strategies, employed in different contexts, on the adoption of a school-based healthy lunchbox program at scale. Importantly, it will also provide evidence as to whether health service-centred, collaborative research models can rapidly generate new knowledge and yield health service improvements.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialAustralian New Zealand Clinical Trials Registry (ANZCTR): 12623000558628Funding StatementCourtney Barnes receives salary support from a NSW Ministry of Health PRSP Research Fellowship. Luke Wolfenden is supported by an NHMRC Investigator Grant (APP11960419) and NSW Cardiovascular Research Capacity Program (H20/28248). Rachel Sutherland is supported by a Medical Research Future Fund Fellowship (APP1150661) and a Hunter New England Clinical Research Fellowship. Jennifer Norman receives salary support from the NSW Ministry of Health PRSP funding awarded to Early Start at the University of Wollongong. Jannah Jones is supported by a Hunter New England Clinical Research Fellowship. Anna Lene Seidler is supported by an NHMRC Investigator Grant (APP2009432). The contents of this manuscript are the responsibility of authors and do not reflect the views of NSW Ministry of Health or NHMRC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval has been obtained via the following Human Research Ethics Committees: Hunter New England (2019/ETH12353); University of Newcastle (09/07/26/4.04); NSW of Department of Education (2018247); and the Maitland-Newcastle, Sydney, Wollongong, Bathurst, Parramatta, Wagga Wagga and Canberra-Goulburn Catholic Dioceses. The trial is prospectively registered with the Australian New Zealand Clinical Trials Registry (ACTRN12623000558628). Consent from schools to participate in the data collection component of the study (i.e. the follow-up survey) will be obtained with approved information statements and consent processes. Participants may withdraw from the study at any time. Evaluation and process data collected as part of the study will be disseminated widely through national and international peer-reviewed publications and conferences presentations.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors